Donald Allen Williams

CIK: 0001620013

Transaction Breakdown

Open Market Buys (P)4 (40.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (20.0%)

Derivative conversions

Awards (A)4 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PALI

PALISADE BIO, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (10 total)

PALI
PALISADE BIO, INC.
Oct 2, 2026
Purchase(P)
Direct
10K shares at avg. $1.46$15K
PALI
PALISADE BIO, INC.
Oct 1, 2026
Purchase(P)
Direct
10K shares at avg. $1.42$14K
PALI
PALISADE BIO, INC.
Jun 10, 2026
Award(A)
Direct
1.5M shares-
PALI
PALISADE BIO, INC.
Jun 10, 2026
Exercise(M)
Direct
60.7K shares-
PALI
PALISADE BIO, INC.
Jan 16, 2026
Purchase(P)
Direct
5K shares at avg. $1.67$8K
PALI
PALISADE BIO, INC.
Jan 9, 2026
Purchase(P)
Direct
5K shares at avg. $1.88$9K
PALI
PALISADE BIO, INC.
Oct 6, 2025
Award(A)
Restricted Stock Units
Direct
182K shares-
PALI
PALISADE BIO, INC.
Oct 6, 2025
Award(A)
Restricted Stock Units
Direct
1.5M shares-
PALI
PALISADE BIO, INC.
Sep 4, 2025
Award(A)
Phantom Units
Direct
64.4K shares-
PALI
PALISADE BIO, INC.
Nov 21, 2024
Exercise(M)
Direct
388 shares-

		Type	Shares	Price		Ownership
Oct 2, 2026	PALI PALISADE BIO, INC.	Purchase(P)	10,000	$1.46	$14,600	Direct
Oct 1, 2026	PALI PALISADE BIO, INC.	Purchase(P)	10,000	$1.42	$14,200	Direct
Jun 10, 2026	PALI PALISADE BIO, INC.	Award(A)	1,498,900	-	$0	Direct
Jun 10, 2026	PALI PALISADE BIO, INC.	Exercise(M)	60,666	-	$0	Direct
Jan 16, 2026	PALI PALISADE BIO, INC.	Purchase(P)	5,000	$1.67	$8,356	Direct
Jan 9, 2026	PALI PALISADE BIO, INC.	Purchase(P)	5,000	$1.88	$9,400	Direct
Oct 6, 2025	PALI PALISADE BIO, INC.	Award(A) Restricted Stock Units	182,000	-	-	Direct
Oct 6, 2025	PALI PALISADE BIO, INC.	Award(A) Restricted Stock Units	1,538,700	-	-	Direct
Sep 4, 2025	PALI PALISADE BIO, INC.	Award(A) Phantom Units	64,400	-	-	Direct
Nov 21, 2024	PALI PALISADE BIO, INC.	Exercise(M)	388	-	$0	Direct

1-10 of 10 transactions

About Williams Donald Allen

Williams Donald Allen (SEC CIK 0001620013) files insider reports with the SEC as Director of PALISADE BIO, INC. (PALI).

Signal8 holds 8 ownership filings by Williams Donald Allen, all Form 4s, filed between Nov 22, 2024 and Oct 5, 2026. Those filings report 10 transactions, from Nov 21, 2024 to Oct 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Williams Donald Allen's filings is in DENVER, CO.

Recent filings by Williams Donald Allen

Oct 2, 2026: Open-market purchase of PALI shares (Form 4, code P).
Oct 1, 2026: Open-market purchase of PALI shares (Form 4, code P).
Jun 10, 2026: Grant or award of PALI shares (Form 4, code A).
Jun 10, 2026: Option exercise of PALI shares (Form 4, code M).
Jan 16, 2026: Open-market purchase of PALI shares (Form 4, code P).

Other insiders filing for PALISADE BIO, INC. (PALI)

How to read Form 4 transaction codes